论文部分内容阅读
The oncolytic virus was recently become a very hot topic and OncoHSV-GM-CSF has been licensed to be marketed by FDA.We innovate the Cancer Targeting Gene-Viro-Therapy,CTGVT,constructed by inserting an antitumor into the OV (OV-gene),it is actually OV-gene therapy.